These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 18663327)

  • 1. Validation of the Toronto formula to predict progression in IgA nephropathy.
    Mackinnon B; Fraser EP; Cattran DC; Fox JG; Geddes CC
    Nephron Clin Pract; 2008; 109(3):c148-53. PubMed ID: 18663327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting progression in IgA nephropathy.
    Bartosik LP; Lajoie G; Sugar L; Cattran DC
    Am J Kidney Dis; 2001 Oct; 38(4):728-35. PubMed ID: 11576875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary excretion of low-molecular-weight proteins as prognostic markers in IgA nephropathy.
    Peters HP; van den Brand JA; Wetzels JF
    Neth J Med; 2009 Feb; 67(2):54-61. PubMed ID: 19299847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors predicting progression of IgA nephropathies.
    Coppo R; D'Amico G
    J Nephrol; 2005; 18(5):503-12. PubMed ID: 16299675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
    Draman CR; Kong NC; Gafor AH; Rahman AF; Zainuddin S; Mustaffa WM; Radzi AM; Shamsul AS
    Singapore Med J; 2008 Nov; 49(11):924-9. PubMed ID: 19037561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A scoring system to predict renal outcome in IgA nephropathy: from a nationwide prospective study.
    Wakai K; Kawamura T; Endoh M; Kojima M; Tomino Y; Tamakoshi A; Ohno Y; Inaba Y; Sakai H
    Nephrol Dial Transplant; 2006 Oct; 21(10):2800-8. PubMed ID: 16822793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of sex in primary glomerulonephritis.
    Cattran DC; Reich HN; Beanlands HJ; Miller JA; Scholey JW; Troyanov S;
    Nephrol Dial Transplant; 2008 Jul; 23(7):2247-53. PubMed ID: 18182409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Point of no return (PNR)" in progressive IgA nephropathy: significance of blood pressure and proteinuria management up to PNR.
    Komatsu H; Fujimoto S; Sato Y; Hara S; Yamada K; Morita S; Eto T
    J Nephrol; 2005; 18(6):690-5. PubMed ID: 16358226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presentation, prognosis and outcome of IgA nephropathy in Indian adults.
    Chacko B; John GT; Neelakantan N; Korula A; Balakrishnan N; Kirubakaran MG; Jacob CK
    Nephrology (Carlton); 2005 Oct; 10(5):496-503. PubMed ID: 16221102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular diseases and their risk factors in IgA nephropathy.
    Myllymäki J; Syrjänen J; Helin H; Pasternack A; Kattainen A; Mustonen J
    Nephrol Dial Transplant; 2006 Jul; 21(7):1876-82. PubMed ID: 16522659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A validated model of disease progression in IgA nephropathy.
    Magistroni R; Furci L; Leonelli M; Masellis M; Ligabue G; Lucchi L; Lupo A; Brezzi B; Gambaro G; Manganelli L; Pedrazzi G; Ricardi M; Bormioli L; Albertazzi A
    J Nephrol; 2006; 19(1):32-40. PubMed ID: 16523423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fractional urinary excretion of IgG is the most powerful predictor of renoprotection by ACE inhibitors in IgA nephropathy.
    Bazzi C; Rizza V; Paparella M; Casellato D; Napodano P; Olivieri G; D'Amico G
    J Nephrol; 2009; 22(3):387-96. PubMed ID: 19557716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgA nephropathy: multivariate statistical analysis aimed at predicting outcome.
    Fofi C; Pecci G; Galliani M; Comunian MC; Muda AO; Pierucci A; Cinotti GA
    J Nephrol; 2001; 14(4):280-5. PubMed ID: 11506251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort.
    Levin A; Djurdjev O; Beaulieu M; Er L
    Am J Kidney Dis; 2008 Oct; 52(4):661-71. PubMed ID: 18805347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A tricontinental view of IgA nephropathy.
    Geddes CC; Rauta V; Gronhagen-Riska C; Bartosik LP; Jardine AG; Ibels LS; Pei Y; Cattran DC
    Nephrol Dial Transplant; 2003 Aug; 18(8):1541-8. PubMed ID: 12897092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical course and prognostic factors of clinical early IgA nephropathy.
    Shen P; He L; Huang D
    Neth J Med; 2008 Jun; 66(6):242-7. PubMed ID: 18689907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasculitic IgA nephropathy: prognosis and outcome.
    Pankhurst T; Lepenies J; Nightingale P; Howie AJ; Adu D; Harper L
    Nephron Clin Pract; 2009; 112(1):c16-24. PubMed ID: 19342865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of early progression in recently diagnosed IgA nephropathy.
    Lemley KV; Lafayette RA; Derby G; Blouch KL; Anderson L; Efron B; Myers BD
    Nephrol Dial Transplant; 2008 Jan; 23(1):213-22. PubMed ID: 17890749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgA nephropathy in Czech patients--are we able reliably predict the outcome?
    Maixnerova D; Neprasova M; Skibova J; Mokrisova J; Rysava R; Reiterova J; Jancova E; Merta M; Zadrazil J; Honsova E; Tesar V
    Kidney Blood Press Res; 2014; 39(6):555-62. PubMed ID: 25531750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focal segmental glomerulosclerosis in mild IgA nephropathy: a clinical-pathologic study.
    Weber CL; Rose CL; Magil AB
    Nephrol Dial Transplant; 2009 Feb; 24(2):483-8. PubMed ID: 18786972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.